Fusion Biopsy Market Size, Share, and Trends 2026 to 2035

Fusion Biopsy Market (By Biopsy Route: Transrectal, Transperineal; By End Use: Hospitals, Diagnostic Centers, Ambulatory Care Centers) – Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2026 to 2035.

Last Updated : 09 Jan 2026  |  Report Code : 5350  |  Category : Healthcare   |  Format : PDF / PPT / Excel

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Fusion Biopsy Market 

5.1. COVID-19 Landscape: Fusion Biopsy Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Fusion Biopsy Market, By Product Type

8.1. Fusion Biopsy Market, by Product Type

8.1.1. Equipment (Systems)

8.1.1.1. Market Revenue and Forecast

8.1.2. Software

8.1.2.1. Market Revenue and Forecast

8.1.3. Consumables & Accessories

8.1.3.1. Market Revenue and Forecast

Chapter 9. Global Fusion Biopsy Market, By Biopsy Route

9.1. Fusion Biopsy Market, by Biopsy Route

9.1.1. Transrectal (TRUS–MRI Fusion)

9.1.1.1. Market Revenue and Forecast

9.1.2. Transperineal (TP–MRI Fusion)

9.1.2.1. Market Revenue and Forecast

Chapter 10. Global Fusion Biopsy Market, By Fusion Technique

10.1. Fusion Biopsy Market, by Fusion Technique

10.1.1. Software-Based Fusion

10.1.1.1. Market Revenue and Forecast

10.1.2. Cognitive Fusion (Visual / Manual Estimation)

10.1.2.1. Market Revenue and Forecast

10.1.3. In-Bore MRI Fusion (Direct MRI-Guided Biopsy)

10.1.3.1. Market Revenue and Forecast

Chapter 11. Global Fusion Biopsy Market, By Application

11.1. Fusion Biopsy Market, by Application

11.1.1. Prostate Cancer Diagnosis (Primary)

11.1.1.1. Market Revenue and Forecast

11.1.2. Renal (Kidney) Lesion Evaluation

11.1.2.1. Market Revenue and Forecast

11.1.3. Liver Tumor Targeting

11.1.3.1. Market Revenue and Forecast

11.1.4. Active Surveillance Monitoring

11.1.4.1. Market Revenue and Forecast

11.1.5. Focal Therapy Planning

11.1.5.1. Market Revenue and Forecast

Chapter 12. Global Fusion Biopsy Market, By End-User

12.1. Fusion Biopsy Market, by End-User

12.1.1. Hospitals & Tertiary Care Centers

12.1.1.1. Market Revenue and Forecast

12.1.2. Specialized Oncology Clinics

12.1.2.1. Market Revenue and Forecast

12.1.3. Diagnostic Imaging Centers

12.1.3.1. Market Revenue and Forecast

12.1.4. Ambulatory Surgical Centers (ASCs)

12.1.4.1. Market Revenue and Forecast

12.1.5. Academic & Research Institutions

12.1.5.1. Market Revenue and Forecast

Chapter 13. Global Fusion Biopsy Market, By Distribution Channel

13.1. Fusion Biopsy Market, by Distribution Channel

13.1.1. Direct Sales (Institutional Procurement)

13.1.1.1. Market Revenue and Forecast

13.1.2. Indirect Sales (Medical Device Distributors)

13.1.2.1. Market Revenue and Forecast

Chapter 14. Global Fusion Biopsy Market, Regional Estimates and Trend Forecast

14.1. North America

14.1.1. Market Revenue and Forecast, by Product Type

14.1.2. Market Revenue and Forecast, by Biopsy Route

14.1.3. Market Revenue and Forecast, by Fusion Technique

14.1.4. Market Revenue and Forecast, by Application

14.1.5. Market Revenue and Forecast, by End-User

14.1.6. Market Revenue and Forecast, by Distribution Channel

14.1.7. U.S.

14.1.7.1. Market Revenue and Forecast, by Product Type

14.1.7.2. Market Revenue and Forecast, by Biopsy Route

14.1.7.3. Market Revenue and Forecast, by Fusion Technique

14.1.7.4. Market Revenue and Forecast, by Application

14.1.8. Market Revenue and Forecast, by End-User

14.1.8.1. Market Revenue and Forecast, by Distribution Channel  

14.1.9. Rest of North America

14.1.9.1. Market Revenue and Forecast, by Product Type

14.1.9.2. Market Revenue and Forecast, by Biopsy Route

14.1.9.3. Market Revenue and Forecast, by Fusion Technique

14.1.9.4. Market Revenue and Forecast, by Application

14.1.10. Market Revenue and Forecast, by End-User

14.1.11. Market Revenue and Forecast, by Distribution Channel

14.1.11.1.

14.2. Europe

14.2.1. Market Revenue and Forecast, by Product Type

14.2.2. Market Revenue and Forecast, by Biopsy Route

14.2.3. Market Revenue and Forecast, by Fusion Technique

14.2.4. Market Revenue and Forecast, by Application  

14.2.5. Market Revenue and Forecast, by End-User

14.2.6. Market Revenue and Forecast, by Distribution Channel

14.2.7.

14.2.8. UK

14.2.8.1. Market Revenue and Forecast, by Product Type

14.2.8.2. Market Revenue and Forecast, by Biopsy Route

14.2.8.3. Market Revenue and Forecast, by Fusion Technique

14.2.9. Market Revenue and Forecast, by Application  

14.2.10. Market Revenue and Forecast, by End-User

14.2.10.1. Market Revenue and Forecast, by Distribution Channel  

14.2.11. Germany

14.2.11.1. Market Revenue and Forecast, by Product Type

14.2.11.2. Market Revenue and Forecast, by Biopsy Route

14.2.11.3. Market Revenue and Forecast, by Fusion Technique

14.2.12. Market Revenue and Forecast, by Application

14.2.13. Market Revenue and Forecast, by End-User

14.2.14. Market Revenue and Forecast, by Distribution Channel

14.2.14.1.

14.2.15. France

14.2.15.1. Market Revenue and Forecast, by Product Type

14.2.15.2. Market Revenue and Forecast, by Biopsy Route

14.2.15.3. Market Revenue and Forecast, by Fusion Technique

14.2.15.4. Market Revenue and Forecast, by Application

14.2.16. Market Revenue and Forecast, by End-User

14.2.16.1. Market Revenue and Forecast, by Distribution Channel

14.2.17. Rest of Europe

14.2.17.1. Market Revenue and Forecast, by Product Type

14.2.17.2. Market Revenue and Forecast, by Biopsy Route

14.2.17.3. Market Revenue and Forecast, by Fusion Technique

14.2.17.4. Market Revenue and Forecast, by Application

14.2.18. Market Revenue and Forecast, by End-User

14.2.18.1. Market Revenue and Forecast, by Distribution Channel

14.3. APAC

14.3.1. Market Revenue and Forecast, by Product Type

14.3.2. Market Revenue and Forecast, by Biopsy Route

14.3.3. Market Revenue and Forecast, by Fusion Technique

14.3.4. Market Revenue and Forecast, by Application

14.3.5. Market Revenue and Forecast, by End-User

14.3.6. Market Revenue and Forecast, by Distribution Channel

14.3.7. India

14.3.7.1. Market Revenue and Forecast, by Product Type

14.3.7.2. Market Revenue and Forecast, by Biopsy Route

14.3.7.3. Market Revenue and Forecast, by Fusion Technique

14.3.7.4. Market Revenue and Forecast, by Application

14.3.8. Market Revenue and Forecast, by End-User

14.3.9. Market Revenue and Forecast, by Distribution Channel

14.3.10. China

14.3.10.1. Market Revenue and Forecast, by Product Type

14.3.10.2. Market Revenue and Forecast, by Biopsy Route

14.3.10.3. Market Revenue and Forecast, by Fusion Technique

14.3.10.4. Market Revenue and Forecast, by Application

14.3.11. Market Revenue and Forecast, by End-User

14.3.11.1. Market Revenue and Forecast, by Distribution Channel

14.3.12. Japan

14.3.12.1. Market Revenue and Forecast, by Product Type

14.3.12.2. Market Revenue and Forecast, by Biopsy Route

14.3.12.3. Market Revenue and Forecast, by Fusion Technique

14.3.12.4. Market Revenue and Forecast, by Application

14.3.12.5. Market Revenue and Forecast, by End-User

14.3.12.6. Market Revenue and Forecast, by Distribution Channel

14.3.13. Rest of APAC

14.3.13.1. Market Revenue and Forecast, by Product Type

14.3.13.2. Market Revenue and Forecast, by Biopsy Route

14.3.13.3. Market Revenue and Forecast, by Fusion Technique

14.3.13.4. Market Revenue and Forecast, by Application

14.3.13.5. Market Revenue and Forecast, by End-User

14.3.13.6. Market Revenue and Forecast, by Distribution Channel

14.4. MEA

14.4.1. Market Revenue and Forecast, by Product Type

14.4.2. Market Revenue and Forecast, by Biopsy Route

14.4.3. Market Revenue and Forecast, by Fusion Technique

14.4.4. Market Revenue and Forecast, by Application

14.4.5. Market Revenue and Forecast, by End-User

14.4.6. Market Revenue and Forecast, by Distribution Channel

14.4.7. GCC

14.4.7.1. Market Revenue and Forecast, by Product Type

14.4.7.2. Market Revenue and Forecast, by Biopsy Route

14.4.7.3. Market Revenue and Forecast, by Fusion Technique

14.4.7.4. Market Revenue and Forecast, by Application

14.4.8. Market Revenue and Forecast, by End-User

14.4.9. Market Revenue and Forecast, by Distribution Channel

14.4.10. North Africa

14.4.10.1. Market Revenue and Forecast, by Product Type

14.4.10.2. Market Revenue and Forecast, by Biopsy Route

14.4.10.3. Market Revenue and Forecast, by Fusion Technique

14.4.10.4. Market Revenue and Forecast, by Application

14.4.11. Market Revenue and Forecast, by End-User

14.4.12. Market Revenue and Forecast, by Distribution Channel

14.4.13. South Africa

14.4.13.1. Market Revenue and Forecast, by Product Type

14.4.13.2. Market Revenue and Forecast, by Biopsy Route

14.4.13.3. Market Revenue and Forecast, by Fusion Technique

14.4.13.4. Market Revenue and Forecast, by Application

14.4.13.5. Market Revenue and Forecast, by End-User

14.4.13.6. Market Revenue and Forecast, by Distribution Channel

14.4.14. Rest of MEA

14.4.14.1. Market Revenue and Forecast, by Product Type

14.4.14.2. Market Revenue and Forecast, by Biopsy Route

14.4.14.3. Market Revenue and Forecast, by Fusion Technique

14.4.14.4. Market Revenue and Forecast, by Application

14.4.14.5. Market Revenue and Forecast, by End-User

14.4.14.6. Market Revenue and Forecast, by Distribution Channel

14.5. Latin America

14.5.1. Market Revenue and Forecast, by Product Type

14.5.2. Market Revenue and Forecast, by Biopsy Route

14.5.3. Market Revenue and Forecast, by Fusion Technique

14.5.4. Market Revenue and Forecast, by Application

14.5.5. Market Revenue and Forecast, by End-User

14.5.6. Market Revenue and Forecast, by Distribution Channel

14.5.7. Brazil

14.5.7.1. Market Revenue and Forecast, by Product Type

14.5.7.2. Market Revenue and Forecast, by Biopsy Route

14.5.7.3. Market Revenue and Forecast, by Fusion Technique

14.5.7.4. Market Revenue and Forecast, by Application

14.5.8. Market Revenue and Forecast, by End-User

14.5.8.1. Market Revenue and Forecast, by Distribution Channel

14.5.9. Rest of LATAM

14.5.9.1. Market Revenue and Forecast, by Product Type

14.5.9.2. Market Revenue and Forecast, by Biopsy Route

14.5.9.3. Market Revenue and Forecast, by Fusion Technique

14.5.9.4. Market Revenue and Forecast, by Application

14.5.9.5. Market Revenue and Forecast, by End-User

14.5.9.6. Market Revenue and Forecast, by Distribution Channel

Chapter 15. Company Profiles

15.1. Eigen

15.1.1. Company Overview

15.1.2. Product Offerings

15.1.3. Financial Performance

15.1.4. Recent Initiatives

15.2. Koninklijke Philips N.V.

15.2.1. Company Overview

15.2.2. Product Offerings

15.2.3. Financial Performance

15.2.4. Recent Initiatives

15.3. Hitachi Ltd.

15.3.1. Company Overview

15.3.2. Product Offerings

15.3.3. Financial Performance

15.3.4. Recent Initiatives

15.4. MedCom

15.4.1. Company Overview

15.4.2. Product Offerings

15.4.3. Financial Performance

15.4.4. Recent Initiatives

15.5. ESAOTE SPA

15.5.1. Company Overview

15.5.2. Product Offerings

15.5.3. Financial Performance

15.5.4. Recent Initiatives

15.6. KOELIS

15.6.1. Company Overview

15.6.2. Product Offerings

15.6.3. Financial Performance

15.6.4. Recent Initiatives

15.7. Focal Healthcare

15.7.1. Company Overview

15.7.2. Product Offerings

15.7.3. Financial Performance

15.7.4. Recent Initiatives

15.8. BK Medical Holding Company, Inc.

15.8.1. Company Overview

15.8.2. Product Offerings

15.8.3. Financial Performance

15.8.4. Recent Initiatives

15.9. Exact Imaging

15.9.1. Company Overview

15.9.2. Product Offerings

15.9.3. Financial Performance

15.9.4. Recent Initiatives

15.10. Biobot Surgical Pte Ltd.

15.10.1. Company Overview

15.10.2. Product Offerings

15.10.3. Financial Performance

15.10.4. Recent Initiatives

Chapter 16. Research Methodology

16.1. Primary Research

16.2. Secondary Research

16.3. Assumptions

Chapter 17. Appendix

17.1. About Us

17.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

Answer : The global fusion biopsy market size is expected to grow from USD 356.8 million in 2025 to USD 803.5 million by 2035.

Answer : The fusion biopsy market is anticipated to grow at a CAGR of 8.6% between 2026 and 2035.

Answer : The major players operating in the fusion biopsy market are Eigen, Koninklijke Philips N.V., Hitachi Ltd., MedCom, ESAOTE SPA, KOELIS, Focal Healthcare, BK Medical Holding Company, Inc., Exact Imaging, Biobot Surgical Pte Ltd., UC-Care Medical Systems Ltd, and Others.

Answer : The driving factors of the fusion biopsy market are the increasing incidence of prostate cancer worldwide also advancements in molecular profiling, coupled with the development of technology.

Answer : North America region will lead the global fusion biopsy market during the forecast period 2026 to 2035.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client